About Us
Industries
Medical Devices
Medical Devices Classification
Cyber Security
Clinical Consultation
Quality Management System Compliance
Regulatory Compliance, Gap Analysis & Remediation
Clinical Evaluation Report CER
Market Compliance Consulting
Medical Devices Regulation (MDR)
In Vitro Diagnostic Regulation (IVDR)
Performance Evaluation Report (PER)
513g
510K
Pharmaceuticals
Biologics
Cosmetics
Review and Product Classification
Cosmetic Product Safety Reports (CPSR)
Cosmetics Claims and Substantiation Services
Cosmetic Labeling Review
Product Information / Technical File Compilation (PIF)
Go-to-Market Services and Regulatory Intelligence
Research & Development Solutions
Food Supplements & Nutraceuticals
Regulatory Overview and Product Classification
Food Ingredients and Additives
Claims and Substantiation of Claims
Labeling Review
Product Registration/Notification
Go-to-Market Services
Research and Development
Chemicals
Poison Center & Chemical Registry
Reach
Safety Data Sheet
House Hold and Personal Hygiene
Toys & Children Products
Veterinary
Services
Toxicological Risk Assessment
PDE Reports (Permitted Daily Exposure)
OEL & API Categorization
Nitrosamine Impurities
(Q)SAR Assessment
Impurities and Risk Analysis
Clinical Operations
Project Management
Clinical Monitoring
Site Startup
Site Service Solutions
Clinical Trial Site Management Organization (SMO)
Regulatory Affairs
Regulatory Services
Regulatory Strategy & Reports
Regulatory Compliance
Regulatory Consulting
Medical Writings
Compliance Audit and Validation
Clinical Informatics
NGS Data Analysis
Variant Interpretation Services
Content Enrichment Services
Pharma Competitive Insights
Health Economics and Outcomes Research
Registration and Notification
Life Cycle Management
Labeling Services
Pharmacovigilance Services
Environmental Risk Assessment Services
Chemical Registration Services
Artwork Services
Careers
Reports
Request Reports
PDE / OEL Report
Insights
Blogs
Events
Contact us
+44 148 290 6002
+1 786 623 2931
+91 906 383 8956
+91 900 001 9531
info@mavenrs.com
Maven Blogs
All
Food Supplements
Pharmaceuticals
Medical Devices
Cosmetics
Regulatory
Chemicals
September 25, 2026
Pharmaceuticals
Strategic Pharmaceutical Artwork Outsourcing 2026: One Owner, One Accountability
Learn more
September 16, 2026
Pharmaceuticals
Global Regulatory Labeling Strategy 2026: From Compliance Requirement to Strategic Market Access Driver
Learn more
September 11, 2026
Pharmaceuticals
EMA Web-Based eAF Mandatory 2026: EU Variation Submission, PLM Portal & Digital Regulatory Compliance Guide
Learn more
September 05, 2026
Pharmaceuticals
Target Product Profile (TPP) in Drug Development 2026: Connecting Clinical Strategy, Regulatory Planning and Labeling Success
Learn more
August 29, 2026
Pharmaceuticals
U.S. FDA Issues Warning Letter to Aurobindo Pharma’s Subsidiary Eugia Pharma: 2026 GMP Compliance, OAI Status and Inspection Readiness Guide
Learn more
August 17, 2026
Pharmaceuticals
Egypt Pharmaceutical Serialization & Track and Trace Compliance 2026: EDA Decrees 475/2025 & 161/2025
Learn more
August 12, 2026
Pharmaceuticals
FDA Draft Guidance 2026: Preparing Container Closure Systems and Device Constituent Parts for Biosimilar and Interchangeable Biosimilar Combination Products
Learn more
August 08, 2026
Pharmaceuticals
South Korea Enhances Pharmaceutical Export Opportunities 2026: Preparing for Innovative Pharmaceutical Company Certification and Global Market Expansion
Learn more
August 04, 2026
Pharmaceuticals
CDSCO Medical Device Software Guidance 2026: Preparing for AI, Software-Based Medical Device Regulatory Compliance in India
Learn more
July 28, 2026
Pharmaceuticals
Brazil Pharmaceutical Registration 2026: Preparing for ANVISA Regulatory Compliance and Successful Market Entry
Learn more
July 20, 2026
Pharmaceuticals
ANVISA Biologics Reliance Pathway 2026: Preparing for Brazil's Reliance Framework Under RDC 741/2022 & RDC 875/2024
Learn more
July 13, 2026
Pharmaceuticals
ARTG Submission Readiness 2026: Preparing a Complete and Compliant Australian Therapeutic Goods Submission
Learn more
July 07, 2026
Pharmaceuticals
Bangladesh Pharma Regulations 2026: 3 Regulatory Shifts That Will Shape Pharmaceutical Market Access
Learn more
July 03, 2026
Pharmaceuticals
ICH M7 (Q)SAR Assessments for Mutagenic Impurities: What Pharmaceutical Manufacturers Need to Know About Expert Rule-Based and Statistical Models
Learn more
June 22, 2026
Pharmaceuticals
Dossier Due Diligence for ARTG Submission: What TGA Really Looks for Before Approving Your Pharmaceutical Product
Learn more
June 18, 2026
Pharmaceuticals
Submission-Ready Clinical Study Reports (CSRs): Complete Regulatory Guide for Faster Global Regulatory Reviews
Learn more
June 15, 2026
Pharmaceuticals
eCTD Publishing Services: Top 5 Regulatory Publishing Mistakes That Delay Global Drug Approvals
Learn more
June 11, 2026
Pharmaceuticals
FDA & ICH M15 Guidance 2026: Complete Guide to Model-Informed Drug Development (MIDD) for Regulatory Decision-Making
Learn more
June 06, 2026
Pharmaceuticals
India’s GLP-1 Drug Safety Alert 2026: What the IPC Warning Means for Pharmacovigilance, Patient Safety, and Market Growth
Learn more
June 05, 2026
Pharmaceuticals
Medical Writing for Regulatory Dossiers: The CTD Modules That Make or Break Your Submission
Learn more
May 26, 2026
Pharmaceuticals
Medical Writing in Drug Product Development: Why It Matters Across the Regulatory Lifecycle
Learn more
May 19, 2026
Pharmaceuticals
Entering Japan’s Pharmaceutical Market: Why Regulatory Localization Is the Key to Successful Market Access
Learn more
May 16, 2026
Pharmaceuticals
WHO Bioequivalence Guideline Update 2026: The Future of Global Generic Drug Compliance
Learn more
May 08, 2026
Pharmaceuticals
Toxicological Risk Assessment (TRA) in Non-clinical Medical Writing: The Ultimate Regulatory & Scientific Guide 2026
Learn more
May 04, 2026
Pharmaceuticals
Clinical Trial Monitoring in 2026: The Ultimate Compliance, Quality & Regulatory Strategy Guide
Learn more
April 25, 2026
Pharmaceuticals
Company Core Data Sheet (CCDS) in Pharma: Global Labeling Compliance Strategy 2026
Learn more
April 13, 2026
Pharmaceuticals
CAPA Effectiveness Under ICH GCP E6(R3): FDA Focus on Root Cause Analysis Beyond Human Error (2026 Compliance Guide)
Learn more
April 06, 2026
Pharmaceuticals
505(b)(1) vs 505(b)(2) vs 505(j): Defining the Optimal U.S. Drug Approval Strategy for Faster Market Access
Learn more
April 04, 2026
Pharmaceuticals
Sri Lanka Drug Registration 2026: Complete NMRA Pharmaceutical, OTC & Medicine Approval Guide (MOH, GMP, Dossier & Regulatory Process)
Learn more
March 28, 2026
Pharmaceuticals
UK Clinical Trials Amendment Regulations 2025 (Effective April 2026): Complete MHRA Compliance Guide for Sponsors, ICH E6(R3), IRAS Submissions, Transparency Rules & Clinical Trial Regulatory Strategy
Learn more
Load More
G
X
Back
Make an enquiry
Lets start the conversation!
Send
Sign up to our newsletter
Send
To explore career opportunities with us.
Send
